Your browser doesn't support javascript.
loading
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat.
Riedl, Marc A; Soteres, Daniel; Sublett, J Wesley; Desai, Bhavisha; Tomita, Dianne; Collis, Phil; Bernstein, Jonathan A.
Afiliação
  • Riedl MA; Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, California.
  • Soteres D; Asthma & Allergy Associates P.C., Colorado Springs, Colorado.
  • Sublett JW; Family Allergy & Asthma, Louisville, Kentucky.
  • Desai B; BioCryst Pharmaceuticals, Inc, Durham, North Carolina.
  • Tomita D; BioCryst Pharmaceuticals, Inc, Durham, North Carolina.
  • Collis P; BioCryst Pharmaceuticals, Inc, Durham, North Carolina.
  • Bernstein JA; University of Cincinnati College of Medicine, Cincinnati, Ohio; University of Cincinnati, Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology. Electronic address: bernstja@ucmail.uc.edu.
Ann Allergy Asthma Immunol ; 132(4): 505-511.e1, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38006972
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angioedemas Hereditários Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angioedemas Hereditários Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article